Opko Health, Inc. (OPK): Price and Financial Metrics


Opko Health, Inc. (OPK): $3.06

0.04 (+1.32%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

OPK POWR Grades


  • Value is the dimension where OPK ranks best; there it ranks ahead of 50.35% of US stocks.
  • OPK's strongest trending metric is Value; it's been moving down over the last 179 days.
  • OPK's current lowest rank is in the Growth metric (where it is better than 4.25% of US stocks).

OPK Stock Summary

  • The price/operating cash flow metric for Opko Health Inc is higher than 92.46% of stocks in our set with a positive cash flow.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.42 for Opko Health Inc; that's greater than it is for only 22.09% of US stocks.
  • Over the past twelve months, OPK has reported earnings growth of -93.97%, putting it ahead of merely 19.4% of US stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Opko Health Inc are BRC, JOUT, MTRN, CW, and IOSP.
  • Visit OPK's SEC page to see the company's official filings. To visit the company's web site, go to www.opko.com.

OPK Valuation Summary

  • OPK's EV/EBIT ratio is 26; this is 11.26% lower than that of the median Healthcare stock.
  • OPK's EV/EBIT ratio has moved up 31.6 over the prior 243 months.
  • Over the past 243 months, OPK's price/earnings ratio has gone up 43.8.

Below are key valuation metrics over time for OPK.

Stock Date P/S P/B P/E EV/EBIT
OPK 2021-08-31 1.4 1.5 37.1 26.0
OPK 2021-08-30 1.4 1.5 36.9 25.9
OPK 2021-08-27 1.4 1.5 37.1 26.0
OPK 2021-08-26 1.3 1.5 36.3 25.5
OPK 2021-08-25 1.4 1.5 36.7 25.8
OPK 2021-08-24 1.3 1.5 36.3 25.5

OPK Growth Metrics

    The 5 year cash and equivalents growth rate now stands at -80.27%.
  • The 5 year net cashflow from operations growth rate now stands at -98.75%.
  • The 4 year net income to common stockholders growth rate now stands at -490.51%.
OPK's revenue has moved up $609,638,000 over the prior 15 months.

The table below shows OPK's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 1,774.718 38.337 -30.143
2021-09-30 1,868.06 78.238 75.929
2021-06-30 1,910.311 107.853 70.907
2021-03-31 1,769.11 108.883 120.796
2020-12-31 1,435.413 39.476 30.586
2020-09-30 1,165.08 -40.819 -114.062

OPK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • OPK has a Quality Grade of C, ranking ahead of 62.7% of graded US stocks.
  • OPK's asset turnover comes in at 0.76 -- ranking 36th of 682 Pharmaceutical Products stocks.
  • LFVN, GBT, and SYRS are the stocks whose asset turnover ratios are most correlated with OPK.

The table below shows OPK's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.760 0.347 0.102
2021-06-30 0.781 0.347 0.094
2021-03-31 0.730 0.368 0.140
2020-12-31 0.611 0.377 0.063
2020-09-30 0.505 0.384 -0.079
2020-06-30 0.418 0.392 -0.157

OPK Price Target

For more insight on analysts targets of OPK, see our OPK price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.60 Average Broker Recommendation 1.2 (Strong Buy)

OPK Stock Price Chart Interactive Chart >

Price chart for OPK

OPK Price/Volume Stats

Current price $3.06 52-week high $5.25
Prev. close $3.02 52-week low $2.43
Day low $2.97 Volume 2,618,300
Day high $3.10 Avg. volume 4,639,755
50-day MA $3.17 Dividend yield N/A
200-day MA $3.64 Market Cap 2.09B

Opko Health, Inc. (OPK) Company Bio


Opko Health is a multinational biopharmaceutical and diagnostics company that seeks to establish industry leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise and novel and proprietary technologies. The company was founded in 2005 and is based in Miami, Florida.


OPK Latest News Stream


Event/Time News Detail
Loading, please wait...

OPK Latest Social Stream


Loading social stream, please wait...

View Full OPK Social Stream

Latest OPK News From Around the Web

Below are the latest news stories about Opko Health Inc that investors may wish to consider to help them evaluate OPK as an investment opportunity.

OPKO Health, Inc. (OPK) CEO Phillip Frost on Q4 2021 Results - Earnings Call Transcript

OPKO Health, Inc. (OPK) Q4 2021 Earnings Conference Call February 24, 2022 04:30 PM ET Company Participants Yvonne Briggs - Investor Relations Phillip Frost - Chairman & Chief Executive Officer Steve Rubin - Executive Vice President Jon Cohen - Managing Director, Executive Chairman of BioReference Laboratories Adam Logal - Chief...

SA Transcripts on Seeking Alpha | February 25, 2022

OPKO Health Reports 2021 Fourth Quarter Business Highlights and Financial Results

Conference call begins at 4:30 p.m. Eastern time todayMIAMI, Feb. 24, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended December 31, 2021. Business Highlights Business highlights for the fourth quarter of 2021 and subsequent weeks include the following: NGENLA® (somatrogon) injection granted regulatory approvals in Europe, Japan, Australia and Canada for pediatric growth hormone deficiency. NGENLA® is a once-week

Yahoo | February 24, 2022

7 Insider Stocks to Buy as Execs Snap Them Up

With equity prices soaring to record levels, many execs have cashed out.

Josh Enomoto on InvestorPlace | February 18, 2022

OPKO Health (OPK) Gains As Market Dips: What You Should Know

In the latest trading session, OPKO Health (OPK) closed at $3.15, marking a +0.32% move from the previous day.

Yahoo | February 18, 2022

OPKO Health to Report Fourth Quarter 2021 Financial Results on February 24, 2022

MIAMI, Feb. 17, 2022 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2021 after the close of the U.S. financial markets on Thursday, February 24, 2022. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on February 24th beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encou

Yahoo | February 17, 2022

Read More 'OPK' Stories Here

OPK Price Returns

1-mo 10.47%
3-mo -4.38%
6-mo -25.91%
1-year -21.13%
3-year 62.77%
5-year -51.66%
YTD -36.38%
2021 21.77%
2020 168.71%
2019 -51.16%
2018 -38.57%
2017 -47.31%

Continue Researching OPK

Want to see what other sources are saying about Opko Health Inc's financials and stock price? Try the links below:

Opko Health Inc (OPK) Stock Price | Nasdaq
Opko Health Inc (OPK) Stock Quote, History and News - Yahoo Finance
Opko Health Inc (OPK) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7118 seconds.